These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6385202)

  • 1. [Correlations between clinical, biochemical and anatomo-pathological findings in orthotopic liver transplants in dogs].
    Bacchella T; Machado MC; da Cunha JE; Gonçalez Y; Behmer OA; Duarte MI
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(2):63-8. PubMed ID: 6385202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characterization of rejection in orthoptic liver transplants in dogs. II. Hematologic and biochemical findings].
    Bacchella T; Machado MC; Cunha JE; Gonçalez Y
    Rev Paul Med; 1984; 102(3):92-103. PubMed ID: 6382559
    [No Abstract]   [Full Text] [Related]  

  • 3. Signs of early rejection of liver transplant in dogs.
    Olszewski W; Polański J; Sawicki Z; Machowski Z; Rosnowska M
    Pol Med J; 1972; 11(6):1590-5. PubMed ID: 4572846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical follow-up of the 1st 3 liver transplants performed in Spain].
    Frey González E; Maciá Montserrat M; Orts Costa J
    Med Clin (Barc); 1985 May; 84(17):685-7. PubMed ID: 2861309
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence on the rejection of the canine liver allograft through pregnancy (author's transl)].
    Lie TS; Böhmer F; Nakano H; Ebata H; Möritz B
    Z Immunitatsforsch Exp Klin Immunol; 1974 Apr; 146(5):460-6. PubMed ID: 4282994
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation.
    Shiffman ML; Contos MJ; Luketic VA; Sanyal AJ; Purdum PP; Mills AS; Fisher RA; Posner MP
    Transplantation; 1994 Feb; 57(4):526-32. PubMed ID: 8116036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
    Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
    Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization of rejection in orthotopic liver transplantation in the dog. III. Anatomo-pathological findings].
    Bacchella T; Machado MC; da Cunha JE; Behmer OA; Duarte MI
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(5):215-22. PubMed ID: 6398901
    [No Abstract]   [Full Text] [Related]  

  • 9. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.
    Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T
    Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
    Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
    Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection.
    Neff GW; Montalbano M; Slapak-Green G; Berney T; Bejarano PA; Joshi A; Icardi M; Nery J; Seigo N; Levi D; Weppler D; Pappas P; Ruiz J; Schiff ER; Tzakis AG
    Liver Transpl; 2003 May; 9(5):477-83. PubMed ID: 12740790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation following extracorporeal hypothermia.
    Cree IC; Hayashi T; Bernardez DB
    Can J Surg; 1968 Oct; 11(4):452-63. PubMed ID: 4879063
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.
    Park KM; Hay JE; Lee SG; Lee YJ; Wiesner RH; Porayko MK; Krom RA
    Transplant Proc; 1996 Jun; 28(3):1738-40. PubMed ID: 8658863
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient hyperphosphatasemia after liver transplantation in infancy.
    Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
    Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired initial function in liver grafts from donors > 50 years of age.
    Buckel E; Sanchez-Urdazpal L; Steers J; Sterioff S; Wiesner R; Krom RA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1558-9. PubMed ID: 8442188
    [No Abstract]   [Full Text] [Related]  

  • 16. Human liver transplantation without azathioprine.
    Aune S; Schistad G; Skulberg A
    Surg Gynecol Obstet; 1972 Nov; 135(5):727-8. PubMed ID: 4563508
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein-X (LP-X) in liver disease.
    Ritland S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(2):155-60. PubMed ID: 4697077
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver function in liver transplantations].
    Lima-Gonçalves E; Machado MC; Bevilacqua RG; Cunha JC; Kieffer J; da Cunha JE; Gonçalez Y; Bacchella T; Srougi M; de Araujo Filho JP
    Rev Hosp Clin Fac Med Sao Paulo; 1969; (4):225-38. PubMed ID: 4898750
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolism in canine liver transplantation with and without immunosuppressive therapy.
    Lie TS; Schmitz H; Nakano H; Ebata H; Bartsch G
    Acta Hepatogastroenterol (Stuttg); 1974 Jun; 21(3):203-12. PubMed ID: 4615550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.